Clinical Trial Update: A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787) [Phase 3]

View source ↗

Summary

This document reports results from an extension Phase 3 safety and efficacy study of VI-0521 for long-term treatment of obesity in adults with obesity-related c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2012-08-31